Inventor
Eoin Power
Inventor
Siena, IT
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes27%
PatentTitleYear
9,242,943'1,4 oxazines as BACE1 and/or BACE2 inhibitors'20168,673,894'2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds'20148,389,513'2-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides'20138,188,079'3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines'20127,989,449'4,5-dihydro-oxazol-2-yl amine derivatives'20117,504,396'Substituted heterocyclic compounds and methods of use'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009Based in Abingdon, GB· patent location history
2011–2016Patents assigned to HOFFMANN LA ROCHE (5)· patent assignee history
2011–2013Based in Siena, IT· patent location history
2012–2016Patents assigned to GUBA WOLFGANG (4)· patent assignee history
2012–2016Patents assigned to HILPERT HANS (4)· patent assignee history
2012–2016Patents assigned to MAUSER HARALD (4)· patent assignee history
2012–2016Patents assigned to MAYWEG ALEXANDER V (4)· patent assignee history
2014–2016Based in Blackrock, IE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 5 | 2011–2016 |
| GUBA WOLFGANG | 4 | 2012–2016 |
| HILPERT HANS | 4 | 2012–2016 |
| MAUSER HARALD | 4 | 2012–2016 |
| MAYWEG ALEXANDER V | 4 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Siena, IT | 3 | 2011–2013 |
| Blackrock, IE | 2 | 2014–2016 |
| Abingdon, GB | 1 | 2009 |